Who are Adimab's investors?

Adimab's investors include GrandBanks Capital, LaunchCapital, Lux Capital, Mithril Capital Management, Premji Invest, SV Health Investors, OrbiMed, SV Life Sciences.

Where is Adimab headquartered?

Adimab is headquartered in Vermont, US.

Adimab

Vermont, US · Founded 2007 · 137 employees on LinkedIn · 8 known investors

Find your way into Adimab

Adimab develops proprietary platforms for antibody and protein therapeutic discovery, engineering fully-functional immunoglobulins in a controllable in vitro eukaryotic system. The company partners with biopharma firms to accelerate the development of transformative protein therapeutics from discovery through clinical progression.

AI & Machine Learning Biotech Deep Tech

Investors · 8

GrandBanks Capitallisted by GrandBanks CapitalNeedham

LaunchCapitallisted by LaunchCapitalBoston · $50K – $150K

How we know: LaunchCapital's portfolio page · the VCSheet dataset · Not right? Tell us

Lux Capitallisted by Lux CapitalNew York · $100K – $100M

How we know: Lux Capital's portfolio page · a partner's Signal profile · Not right? Tell us

Mithril Capital Managementlisted by Mithril Capital ManagementAustin

How we know: Mithril Capital Management's portfolio page · the VCSheet dataset · Not right? Tell us

Premji Investlisted by Premji InvestMenlo Park

SV Health Investorslisted by SV Health InvestorsLondon · $1M – $20M

How we know: SV Health Investors's portfolio page · Not right? Tell us

OrbiMedreportedNew York · $1M – $75M

How we know: funding news · Not right? Tell us

SV Life SciencesreportedBoston

How we know: funding news · Not right? Tell us

Founder mafia

3 people who came through Adimab went on to found or lead other companies.

Errik AndersonCo-FounderFounded Cantai Therapeutics +4 Hemanta BaruahScientist II in Antibody engineeringFounded Aakha Nancy ThornberryMember, Board of DirectorsFounded Kallyope

In the news

Adimab LLC. Raises $13.8 Million Series F Financing, Gets New Digs to Accomodate Growth - BioSpacebiospace.com · Apr 2012

Frequently asked questions

What does Adimab do?: Adimab develops proprietary platforms for antibody and protein therapeutic discovery, engineering fully-functional immunoglobulins in a controllable in vitro eukaryotic system. The company partners with biopharma firms to accelerate the development of transformative protein therapeutics from discovery through clinical progression.
Who are Adimab's investors?: Adimab's investors include GrandBanks Capital, LaunchCapital, Lux Capital, Mithril Capital Management, Premji Invest, SV Health Investors, OrbiMed, SV Life Sciences.
Where is Adimab headquartered?: Adimab is headquartered in Vermont, US.